Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 17 | 2020 | 142 | 4.430 |
Why?
|
| Cell Differentiation | 13 | 2020 | 394 | 2.430 |
Why?
|
| Interferon Regulatory Factors | 5 | 2020 | 58 | 1.940 |
Why?
|
| Estrogen Receptor alpha | 5 | 2015 | 26 | 1.220 |
Why?
|
| Immunity, Innate | 3 | 2016 | 204 | 1.090 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2020 | 58 | 0.970 |
Why?
|
| Estrogens | 5 | 2015 | 56 | 0.960 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2021 | 31 | 0.820 |
Why?
|
| Receptors, Estrogen | 4 | 2012 | 41 | 0.810 |
Why?
|
| Lymphocyte Activation | 4 | 2021 | 203 | 0.810 |
Why?
|
| Mice | 27 | 2025 | 4389 | 0.800 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2019 | 56 | 0.770 |
Why?
|
| Estrogen Receptor beta | 2 | 2015 | 13 | 0.750 |
Why?
|
| Signal Transduction | 9 | 2024 | 1332 | 0.750 |
Why?
|
| Bone Marrow Cells | 5 | 2009 | 79 | 0.740 |
Why?
|
| Animals | 32 | 2025 | 9918 | 0.730 |
Why?
|
| Natural Killer T-Cells | 3 | 2016 | 54 | 0.710 |
Why?
|
| Estradiol | 5 | 2009 | 174 | 0.710 |
Why?
|
| Immunologic Memory | 1 | 2019 | 58 | 0.640 |
Why?
|
| Influenza A virus | 1 | 2019 | 29 | 0.640 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 90 | 0.630 |
Why?
|
| Cells, Cultured | 12 | 2023 | 967 | 0.600 |
Why?
|
| Inflammation | 4 | 2025 | 594 | 0.580 |
Why?
|
| Macrophages | 6 | 2019 | 272 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 1468 | 0.560 |
Why?
|
| Inflammation Mediators | 4 | 2017 | 152 | 0.560 |
Why?
|
| Lung | 5 | 2021 | 346 | 0.550 |
Why?
|
| West Nile virus | 1 | 2016 | 20 | 0.550 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 37 | 0.490 |
Why?
|
| Mice, Knockout | 9 | 2019 | 779 | 0.470 |
Why?
|
| Antigen-Presenting Cells | 4 | 2012 | 31 | 0.470 |
Why?
|
| Cytokines | 5 | 2025 | 437 | 0.420 |
Why?
|
| CD11b Antigen | 3 | 2012 | 42 | 0.420 |
Why?
|
| Sex Characteristics | 3 | 2015 | 162 | 0.410 |
Why?
|
| Immune System | 1 | 2012 | 29 | 0.400 |
Why?
|
| Lymph Nodes | 1 | 2012 | 95 | 0.400 |
Why?
|
| Histocompatibility Antigens Class II | 7 | 2009 | 58 | 0.400 |
Why?
|
| Antigen Presentation | 10 | 2009 | 78 | 0.400 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2009 | 19 | 0.390 |
Why?
|
| Homeostasis | 1 | 2012 | 113 | 0.390 |
Why?
|
| Skin | 1 | 2012 | 139 | 0.380 |
Why?
|
| Female | 17 | 2024 | 14408 | 0.380 |
Why?
|
| T-Lymphocytes | 6 | 2021 | 272 | 0.380 |
Why?
|
| CD11c Antigen | 2 | 2016 | 10 | 0.370 |
Why?
|
| Cell Movement | 1 | 2012 | 352 | 0.360 |
Why?
|
| Adipose Tissue | 2 | 2025 | 179 | 0.350 |
Why?
|
| Autoantigens | 4 | 2007 | 210 | 0.330 |
Why?
|
| Dehydroepiandrosterone | 1 | 2008 | 14 | 0.320 |
Why?
|
| Growth Inhibitors | 2 | 2005 | 11 | 0.320 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 624 | 0.310 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2008 | 2 | 0.310 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 47 | 0.290 |
Why?
|
| Male | 11 | 2025 | 12824 | 0.260 |
Why?
|
| Langerhans Cells | 1 | 2005 | 3 | 0.260 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 3 | 2007 | 12 | 0.260 |
Why?
|
| Interferon Type I | 2 | 2017 | 55 | 0.260 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2005 | 8 | 0.260 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2005 | 8 | 0.260 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2007 | 132 | 0.260 |
Why?
|
| Tamoxifen | 1 | 2005 | 30 | 0.250 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 34 | 0.240 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2009 | 981 | 0.230 |
Why?
|
| Membrane Proteins | 1 | 2008 | 466 | 0.230 |
Why?
|
| Interferon-gamma | 3 | 2021 | 102 | 0.230 |
Why?
|
| Ovary | 1 | 2024 | 69 | 0.220 |
Why?
|
| HLA-DR4 Antigen | 1 | 2002 | 2 | 0.210 |
Why?
|
| Communicable Diseases | 1 | 2023 | 19 | 0.210 |
Why?
|
| Humans | 17 | 2024 | 26755 | 0.210 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 89 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1391 | 0.200 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 48 | 0.200 |
Why?
|
| Adjuvants, Immunologic | 3 | 2022 | 62 | 0.190 |
Why?
|
| Influenza, Human | 1 | 2022 | 84 | 0.190 |
Why?
|
| Smoke | 1 | 2021 | 33 | 0.190 |
Why?
|
| Androgens | 1 | 2020 | 46 | 0.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 42 | 0.180 |
Why?
|
| Coculture Techniques | 2 | 2019 | 53 | 0.180 |
Why?
|
| Protein Binding | 4 | 2016 | 631 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2009 | 14 | 0.170 |
Why?
|
| Peptides | 2 | 2022 | 279 | 0.170 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2009 | 32 | 0.170 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 14 | 0.170 |
Why?
|
| Neutrophils | 2 | 2019 | 177 | 0.170 |
Why?
|
| Autoimmunity | 1 | 2020 | 152 | 0.170 |
Why?
|
| Transcription Factors | 1 | 2023 | 511 | 0.170 |
Why?
|
| Endocytosis | 2 | 2009 | 81 | 0.160 |
Why?
|
| Flow Cytometry | 3 | 2016 | 282 | 0.160 |
Why?
|
| Phagocytosis | 1 | 2019 | 78 | 0.160 |
Why?
|
| Phenotype | 2 | 2020 | 661 | 0.160 |
Why?
|
| H-2 Antigens | 1 | 1998 | 14 | 0.150 |
Why?
|
| Bacillus anthracis | 1 | 2019 | 146 | 0.150 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.150 |
Why?
|
| Antigens, Bacterial | 1 | 2019 | 159 | 0.150 |
Why?
|
| Tobacco Products | 1 | 2021 | 189 | 0.150 |
Why?
|
| Spleen | 2 | 2020 | 109 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 55 | 0.140 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 24 | 0.140 |
Why?
|
| Allergy and Immunology | 1 | 2016 | 5 | 0.140 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2016 | 3 | 0.140 |
Why?
|
| Women | 1 | 2016 | 12 | 0.140 |
Why?
|
| Education, Graduate | 1 | 2016 | 8 | 0.140 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2016 | 12 | 0.140 |
Why?
|
| Macrophages, Alveolar | 1 | 2016 | 35 | 0.140 |
Why?
|
| West Nile Fever | 1 | 2016 | 15 | 0.140 |
Why?
|
| Academies and Institutes | 1 | 2016 | 15 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2016 | 28 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2016 | 58 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2016 | 74 | 0.140 |
Why?
|
| Virus Replication | 1 | 2016 | 55 | 0.140 |
Why?
|
| Faculty | 1 | 2016 | 60 | 0.130 |
Why?
|
| Synovial Membrane | 2 | 2025 | 13 | 0.130 |
Why?
|
| Aging | 1 | 2024 | 940 | 0.130 |
Why?
|
| Lipopolysaccharides | 3 | 2023 | 151 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2016 | 67 | 0.130 |
Why?
|
| Universities | 1 | 2016 | 115 | 0.130 |
Why?
|
| Bacterial Toxins | 1 | 2019 | 265 | 0.130 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 487 | 0.130 |
Why?
|
| Culture Media, Conditioned | 2 | 2005 | 31 | 0.120 |
Why?
|
| Sjogren's Syndrome | 1 | 2017 | 254 | 0.120 |
Why?
|
| B-Lymphocytes | 3 | 2009 | 275 | 0.110 |
Why?
|
| Biomarkers | 1 | 2016 | 729 | 0.110 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2009 | 12 | 0.110 |
Why?
|
| Dynamins | 2 | 2009 | 7 | 0.110 |
Why?
|
| Antigens, Surface | 2 | 2019 | 39 | 0.100 |
Why?
|
| Antigens, CD1d | 1 | 2012 | 45 | 0.100 |
Why?
|
| Cell Count | 2 | 2009 | 84 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 662 | 0.100 |
Why?
|
| Immune Tolerance | 3 | 2009 | 49 | 0.100 |
Why?
|
| Obesity | 1 | 2017 | 645 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2009 | 1254 | 0.090 |
Why?
|
| Retroviridae | 1 | 2009 | 16 | 0.090 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2009 | 7 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 24 | 0.090 |
Why?
|
| Pregnancy | 1 | 2014 | 1126 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 58 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2009 | 23 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2009 | 31 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2009 | 27 | 0.080 |
Why?
|
| Hybridomas | 3 | 2007 | 17 | 0.080 |
Why?
|
| Glycoproteins | 2 | 2016 | 118 | 0.080 |
Why?
|
| Encephalitis | 1 | 2008 | 18 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 1 | 2008 | 24 | 0.080 |
Why?
|
| Brain Stem | 1 | 2008 | 22 | 0.080 |
Why?
|
| Herpes Simplex | 1 | 2008 | 20 | 0.080 |
Why?
|
| Ligands | 1 | 2008 | 168 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2007 | 13 | 0.070 |
Why?
|
| Collagen Type II | 2 | 2007 | 12 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 113 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 263 | 0.070 |
Why?
|
| Mannose-Binding Lectins | 1 | 2005 | 4 | 0.070 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 36 | 0.060 |
Why?
|
| Cell Line | 2 | 2005 | 671 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 2025 | 12 | 0.060 |
Why?
|
| Time Factors | 2 | 2021 | 1564 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2005 | 69 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 140 | 0.060 |
Why?
|
| Interphase | 1 | 2004 | 6 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 16 | 0.060 |
Why?
|
| Oocytes | 1 | 2024 | 24 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2004 | 25 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 153 | 0.060 |
Why?
|
| Fertility | 1 | 2024 | 58 | 0.060 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2023 | 10 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2005 | 644 | 0.050 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2023 | 50 | 0.050 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Lectins | 1 | 2002 | 11 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2002 | 13 | 0.050 |
Why?
|
| Adipokines | 1 | 2002 | 9 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 239 | 0.050 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2022 | 9 | 0.050 |
Why?
|
| Alleles | 2 | 2017 | 347 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 244 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 74 | 0.050 |
Why?
|
| Mutation | 2 | 2020 | 814 | 0.050 |
Why?
|
| Adult | 2 | 2016 | 7353 | 0.050 |
Why?
|
| Cytosol | 1 | 2001 | 47 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 71 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 75 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 239 | 0.040 |
Why?
|
| Transcriptome | 1 | 2020 | 198 | 0.040 |
Why?
|
| Receptors, Vitronectin | 1 | 2019 | 4 | 0.040 |
Why?
|
| Protein S | 1 | 2019 | 26 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2019 | 23 | 0.040 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2019 | 13 | 0.040 |
Why?
|
| Milk Proteins | 1 | 2019 | 18 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2019 | 22 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 52 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2019 | 80 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 66 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 52 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 587 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 22 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2017 | 44 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2017 | 37 | 0.040 |
Why?
|
| Abdominal Fat | 1 | 2017 | 17 | 0.040 |
Why?
|
| Knee Joint | 1 | 2017 | 40 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1998 | 99 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2017 | 38 | 0.040 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2016 | 11 | 0.040 |
Why?
|
| B7-2 Antigen | 1 | 2016 | 8 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 110 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2016 | 33 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2016 | 15 | 0.040 |
Why?
|
| Leptin | 1 | 2017 | 66 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 115 | 0.030 |
Why?
|
| Adipocytes | 1 | 2017 | 53 | 0.030 |
Why?
|
| HLA-D Antigens | 1 | 1996 | 6 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 134 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 130 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 142 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 437 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 283 | 0.030 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2013 | 6 | 0.030 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2013 | 2 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 8 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 2013 | 8 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 9 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 798 | 0.030 |
Why?
|
| Immunization | 1 | 2012 | 117 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2012 | 76 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 254 | 0.020 |
Why?
|
| United States | 1 | 2016 | 2031 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 761 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 503 | 0.020 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2009 | 11 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2009 | 7 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 18 | 0.020 |
Why?
|
| Mice, Inbred NZB | 1 | 2009 | 14 | 0.020 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2009 | 3 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 11 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 50 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 117 | 0.020 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2008 | 1 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2008 | 3 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 5 | 0.020 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Acyclovir | 1 | 2008 | 8 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 557 | 0.020 |
Why?
|
| Eye | 1 | 2008 | 35 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 41 | 0.020 |
Why?
|
| Half-Life | 1 | 2007 | 32 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 277 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2008 | 103 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2007 | 18 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 673 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 5153 | 0.020 |
Why?
|
| Epitopes | 1 | 2007 | 170 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 1034 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2009 | 463 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2007 | 150 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2007 | 235 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2007 | 440 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 6791 | 0.020 |
Why?
|
| Automation | 1 | 2001 | 19 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2001 | 53 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2001 | 128 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2001 | 239 | 0.010 |
Why?
|
| Proteins | 1 | 2001 | 244 | 0.010 |
Why?
|
| Algorithms | 1 | 2001 | 419 | 0.010 |
Why?
|
| HLA-DR5 Antigen | 1 | 1996 | 1 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 250 | 0.010 |
Why?
|
| Transfection | 1 | 1996 | 312 | 0.010 |
Why?
|